WordNet

characterized by or caused by allergy; "an allergic reaction"
having an allergy or peculiar or excessive susceptibility (especially to a specific factor); "allergic children"; "hypersensitive to pollen" (同)hypersensitive, hypersensitized, hypersensitised, sensitized, sensitised, supersensitive, supersensitized, supersensitised
(medicine) any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease
anything that accompanies X and is regarded as an indication of Xs existence

PrepTutorEJDIC

アレルギー性の;(…に)アレルギーを起こす《+『to』+『名』》 / 《補語にのみ用いて》《話》(…に)神経過敏の,(…が)大きらいの《+『to』+『名』(do『ing)』》
(病気の)徴候,症状《+of+名》 / (一般)に(…の)徴候,きざし,印《+of+名》

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.

Luo X1, Ma R, Wu X, Xian D, Li J, Mou Z, Li H.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.Eur Arch Otorhinolaryngol.2015 May;272(5):1165-73. doi: 10.1007/s00405-014-3191-3. Epub 2014 Jul 25.
Azelastine was suggested as a supplementary choice of glucocorticoid for the control of moderate to severe allergic rhinitis (AR). However, the underlying mechanism has not been completely understood. In this study, primary cultured nasal epithelial cells and bronchial epithelial cells were stimulat
PMID 25060977

Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients.

Nony E1, Bouley J, Le Mignon M, Lemoine P, Jain K, Horiot S, Mascarell L, Pallardy M, Vincentelli R, Leone P, Roussel A, Batard T, Abiteboul K, Robin B, de Beaumont O, Arvidsson M, Rak S, Moingeon P.
Allergy.Allergy.2015 Apr 2. doi: 10.1111/all.12622. [Epub ahead of print]
BACKGROUND: Sublingual immunotherapy (SLIT) applied to type I respiratory allergies is commonly performed with natural allergen extracts. Herein, we developed a sublingual tablet made of pharmaceutical-grade recombinant Bet v 1.0101 (rBet v 1) and investigated its clinical safety and efficacy in bir
PMID 25846209

Safety of A New Amino Acid Formula in Infants Allergic to Cow's Milk And Intolerant to Hydrolysates: A Randomized Trial.

Dupont C1, Kalach N, Soulaines P, Bradatan E, Lachaux A, Payot F, De Blay F, Guénard-Bilbault L, Hatahet R, Mulier S, Kapel N, Waligora-Dupriet AJ, Butel MJ.
Journal of pediatric gastroenterology and nutrition.J Pediatr Gastroenterol Nutr.2015 Apr 2. [Epub ahead of print]
INTRODUCTION: Amino acid-based formulas (AAFs) are recommended for children with cow's milk allergy (CMA) failing to respond to extensively hydrolysed formulas (eHFs). We evaluated the effects of a new thickened AAF (TAAF; Novalac®, United Pharmaceuticals, France), containing a pectin-based thicken
PMID 25844709

Safety and efficacy of fluticasone furoate nasal spray in Japanese children 2 to <15 years of age with perennial allergic rhinitis: A multicentre, open-label trial

Okubo Kimihiro,Okamasa Arisa,Honma Gosuke,Komatsubara Masaki
Allergology International 64(1), 60-65, 2015
… Background: Fluticasone furoate nasal spray (FFNS) is a glucocorticoid developed for the treatment of allergic rhinitis (AR). … FFNS 55 μg improved nasal symptom scores and rhinoscopy findings compared with the baseline. … Ocular symptom scores were also improved compared with the baseline in FFNS 55 μg in a sub-group of patients with any ocular symptoms at baseline. …
NAID 130004873122

矢富正徳,北村剛一,清水雅明,大塚康司,鈴木衞
耳鼻咽喉科展望 57(2), 73-81, 2014
　スギ花粉症患者は年々増加傾向であり, 鼻アレルギー診療ガイドライン (改訂第7版) では, ロイコトリエン受容体拮抗薬によるスギ花粉症の初期療法が推奨されている。今回我々は2012年スギ花粉飛散期におけるモンテルカストの初期療法の有効性を検討した。　対象は, 2012年1月から4月までに東京医科大学病院耳鼻咽喉科及び立正佼成会附属佼成病院耳鼻咽喉科を受診した59例である。スギ花粉飛散前にモン …
NAID 130005065305